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Abstract
Background
Variation in blood pressure may relate to dementia risk via autonomic disturbance or hemo-
dynamic mechanisms, but the long-term associations are unclear. We aimed to determine
whether blood pressure variation over a period of years, considering both magnitude and
direction, is associated with the risk of dementia.
Methods and findings
In a prospective cohort study ongoing since 1989 in the Netherlands, 5,273 dementia-free
participants (58.1% women; mean [SD] age, 67.6 [8.0] years) were included. As of 2016,
1,059 dementia cases occurred during a median follow-up of 14.6 years. Absolute variation
in systolic blood pressure (SBP) was assessed as the absolute difference in SBP divided by
the mean over two sequential visits every 4.2 (median) years, with the first quantile set as
the reference level. The direction was the rise or fall in SBP, with the third quantile set as the
reference level. We estimated the risk of dementia in relation to SBP variation measured at
different time windows (i.e., at least 0, 5, 10, and 15 years) prior to dementia diagnosis, with
adjustments for age, sex, education, apolipoprotein E (APOE) genotype, vascular risk fac-
tors, and history of cardiovascular disease. We repeated the above analysis for variation in
diastolic blood pressure (DBP).
A large SBP variation was associated with an increased dementia risk, which became
more pronounced with longer intervals between the assessment of SBP variation and the
diagnosis of dementia. The hazard ratio (HR) associated with large variation (the highest
quintile) increased from 1.08 (95% confidence interval [CI] 0.88–1.34, P = 0.337) for risk
within 5 years of SBP variation measurement to 3.13 (95% CI 2.05–4.77; P < 0.001) for risk
after at least 15 years since the measurement of SBP variation. The increased long-term
risk was associated with both large rises (HR for the highest quintile, 3.31 [95% CI 2.11–
5.18], P < 0.001) and large falls in SBP (HR for the lowest quintile, 2.20 [95% CI 1.33–3.63],
P = 0.002), whereas the higher short-term risk was only associated with large falls in SBP
(HR, 1.21 [95% CI 1.00–1.48], P = 0.017). Similar findings were observed for variation in
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website for more information: http://www.
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the study, and there is potential risk of revealing
DBP. Despite our assessment of major confounders, potential residual confounding is pos-
sible, and the findings on blood pressure variability over periods of years may not be gener-
alizable to variability over periods of days and other shorter periods.
Conclusions
Results of this study showed that a large blood pressure variation over a period of years was
associated with an increased long-term risk of dementia. The association between blood
pressure variation and dementia appears most pronounced when this variation occurred
long before the diagnosis. An elevated long-term risk of dementia was observed with both a
large rise and fall in blood pressure.
Author summary
Why was this study done?
• Blood pressure rises throughout most of life, and hypertension is proposed as an impor-
tant modifiable risk factor for dementia. In late life, the relationship between blood pres-
sure and dementia is controversial.
• Variation in blood pressure is suggested to be associated with dementia risk beyond
absolute blood pressure levels, but the long-term associations are unclear. Whether the
putative associations differ by direction of variation is also unknown.
What did the researchers do and find?
• In this prospective cohort study involving 5,273 dementia-free participants who were
followed over 26 years, a large blood pressure variation, measured over two sequential
visits every 4 years apart, was associated with an increased risk of dementia, especially
when this variation occurred long before the diagnosis.
• Both large rises and falls in blood pressure were associated with a higher long-term risk.
What do these findings mean?
• This study suggests the potential importance of blood pressure variability in the etiology
of dementia.
• If the observed association is causal, our study suggests an opportunity to prevent
dementia through targeting large variation in blood pressure over a period of years
above and beyond the mere control of conventional blood pressure limits.
• The stronger association over longer intervals thereby suggests greater benefits from
interventions implemented earlier in life.
Blood pressure variation and dementia
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Introduction
Dementia is the most common neurodegenerative disease in elderly people, associated with
high disability and dependency [1]. Around 50 million people are living with dementia glob-
ally, and because of the aging population, the number of patients is predicted to triple by 2050,
with global economic costs projected to rise in parallel [1,2].
Vascular risk factors are potentially major modifiable contributors in the multifactorial eti-
ology of cognitive decline and dementia [3]. Hypertension is a particularly important risk fac-
tor, but its relation to dementia becomes complex with aging [4,5]. This association may
depend on time until diagnosis [6], and dynamic effects of blood pressure fluctuation are
unlikely to be captured in a single measurement. Blood pressure variability emerges as a risk
factor for ischemic stroke, with effects beyond absolute blood pressure levels alone [7,8]. It has
also been reported that a larger variability in systolic blood pressure (SBP) and diastolic blood
pressure (DBP) over time is associated with a higher risk of dementia during a follow-up of up
to 8 years [9]. Given the insidious onset of dementia, pathological processes of dementia affect-
ing blood pressure may occur many years before the diagnosis, and short-term associations
may thus be susceptible to reverse causation [10]. It is unknown whether blood pressure varia-
tion is associated with dementia in the long-term and whether the putative association changes
over time. Moreover, there is no consistent evidence on whether the direction of variation—
i.e., rise or fall in blood pressure—is relevant to subsequent dementia risk. The mechanisms
underlying the putative associations, possibly involving vascular stiffness [11], also remain
undetermined.
We investigated the association between blood pressure variation and the risk of dementia
in a prospective cohort study with up to 26 years of follow-up, considering both magnitude
and direction of the variation measured at a range of time intervals prior to the diagnosis of
dementia.
Methods
Ethics statement
The Rotterdam Study has been approved by the institutional review board (Medical Ethics Com-
mittee) of the Erasmus Medical Center and by the review board of The Netherlands Ministry of
Health, Welfare and Sport. Written informed consent has been obtained from all participants.
Study design and data sources
This study is embedded in the Rotterdam Study, a prospective cohort study underway since
1989 in the Ommoord District in the city of Rotterdam, the Netherlands. A detailed descrip-
tion has been published elsewhere [12]. Data were collected following a prospective study pro-
tocol [12]. Statistical analyses were performed following a prospective analysis plan with
prespecified research hypothesis (S1 Text). Briefly, 7,983 participants (out of 10,215 invitees)
aged�55 years have been followed for 26 years (since July 27, 1989, through January 1, 2016),
with the first through fifth examination cycles performed in 1989–1993, 1993–1995, 1997–
1999, 2002–2004, and 2009–2011. The present study includes all participants free of dementia
at the first and second examination cycles. We applied the following exclusion criteria: insuffi-
cient data on dementia status at the first visit (n = 348), prevalent dementia at the first visit
(n = 486), no informed consent for follow-up data collection (n = 100), incident dementia
before the second visit (n = 404), death before completing at least two visits (n = 1,034), and
missing blood pressure measurements at the first two visits (n = 338). Ultimately, 5,273 partici-
pants were eligible for the current study (Fig A in S2 Text). A comparison of eligible versus
Blood pressure variation and dementia
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ineligible participants is provided in the Supporting information (Table A in S2 Text). Eligible
participants were generally younger, had a lower risk profile for vascular disease, and had bet-
ter cognitive function at baseline.
Variation in blood pressure
At each visit, after at least 5 minutes’ rest in a seated position, two blood pressure measure-
ments were taken on the right upper arm. The mean of these two measurements was used for
that visit. Blood pressure was measured in the same way from the first through the fifth visits.
Before November 7, 2006, a Hawksley random-zero sphygmomanometer was used. Omron
M6 Comfort and Omron M7 devices were used thereafter. We assessed variation in SBP, DBP,
and pulse pressure separately and primarily reported results on variability in SBP because of
the stronger association of SBP with adverse health outcomes [13].
Within-individual SBP variation between two sequential visits was assessed at the latter of
the two visits using two measures: (1) variation in SBP as the primary measure to capture the
magnitude of variation and (2) directional variation as a secondary measure to differentiate
rises from falls in SBP. The variation was calculated as the absolute difference in SBP divided
by the mean SBP over two sequential visits (|difference|/mean). Similarly, directional variation
was defined as the difference in SBP between the two visits divided by the mean ([latter − for-
mer]/mean). We assessed SBP variation over a rolling time window of two sequential visits
because it allowed us to better examine lag-specific associations and to differentiate the direc-
tion of SBP variation. To account for different visit intervals (median, 4.2; 25th–75th percen-
tile, 2.0–4.8 years), both measurements were scaled to the average variation per year, assuming
a constant rate of variation between the two visits. As shown in Fig 1, measurements were
assessed as time-varying exposures, first assessed at the second visit using SBP of the first two
visits, and then updated at the third visit using SBP of the second and third visits, and so on.
Of 5,273 participants, 5,088 had valid SBP measured at consecutive visits before censoring,
with the number of visits with SBP measurements ranging from 2 to 5 per participant. For the
185 (3.5%) participants who missed one visit in the middle, variation assessed at the previous
visit was used. The median number of visits with SBP measurements used for each lag analysis
was 4 (lag 0), 4 (lag 5), 4 (lag 10), and 3 (lag 15) per participant.
Ascertainment of dementia
Participants were screened for dementia at baseline and subsequent visits using the Mini-Men-
tal State Examination and the Geriatric Mental Schedule. Participants having a Mini-Mental
State Examination score < 26 or Geriatric Mental State Schedule organic level > 0 underwent
further examination, including the Cambridge Examination for Mental Disorders of the
Elderly. All participants also underwent routine cognitive assessment. Additionally, all partici-
pants were continuously monitored for dementia through electronic linkage with medical rec-
ords from general practitioners and the regional institute for outpatient mental healthcare.
Available information on cognitive testing and clinical neuroimaging was used when required
for diagnosis of dementia subtype. A consensus panel led by a consultant neurologist estab-
lished the final diagnosis according to standard criteria for dementia (the Diagnostic and Sta-
tistical Manual of Mental Disorders, Third Edition, Revised; DSM-III-R), Alzheimer’s disease
(NINCDS-ADRDA), and vascular dementia (NINDS-AIREN) [14].
Covariates
Information on demographic characteristics was collected at the first visit. The apolipoprotein
E (APOE) genotype was determined using polymerase chain reaction on coded genomic DNA
Blood pressure variation and dementia
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samples. During each visit, smoking habits, alcohol consumption, medication use, body mass
index, total cholesterol, high-density lipoprotein cholesterol, and diabetes mellitus were
assessed with standardized protocols. Antihypertensive medication was classified according to
WHO Anatomical Therapeutic Chemical Codes and included antihypertensives (C02), diuret-
ics (C03), beta blockers (C07), calcium channel blockers (C08), and renin-angiotensin system
modifying agents (C09). Cardiovascular disease, including stroke, coronary heart disease,
heart failure, and atrial fibrillation, was assessed via interviews and verified by medical records.
Arterial stiffness was assessed by carotid–femoral pulse wave velocity at the third visit
(n = 3,191) using an automatic device (S3 Text).
Statistical methods
Primary analyses. Our analysis focused on the association between variation in SBP,
assessed over two sequential study visits, and incident dementia. Person-time accrued from
the second visit (first assessment of SBP variation) until the date of dementia diagnosis, date of
death, date of loss to follow-up, or administrative censoring on January 1, 2016, whichever
came first (with near-complete follow-up of 98% of potential person-years). Given the poten-
tially long but unclear latency period for dementia, we performed analyses with varied latency
periods. As shown in Fig 1, we estimated the associations considering four lag periods, defined
as a lag period of 0, 5, 10, and 15 years, respectively. The years of lag represent the minimum
interval between the measurement of SBP variation and the assessment of incident dementia.
Specifically, a lag of 0 years investigated new dementia cases occurring during the visit interval
immediately following the measurement of SBP variation. A lag of 5 years investigated new
dementia cases occurring at least 5 years after the measurement of SBP variation, and so on. In
the lag 5 analysis, individuals with a follow-up of less than 5 years were not included, because
Fig 1. Schematic diagram of the analyses relating BP variation to the risk of dementia at different lag periods. aThe years of lag
indicate the minimum interval between the measurement of BP variation and the assessment of incident dementia. A lag of 0
examined the risk of dementia during the visit interval immediately following the measurement of BP variation. A lag of 5 years
investigated the risk of dementia occurring at least 5 years after the measurement of BP variation, in which dementia cases occurring
within the first 5 years of follow-up were censored, and so on. BP, blood pressure.
https://doi.org/10.1371/journal.pmed.1002933.g001
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they did not have measurements on SBP variation at the specified time windows. Likewise,
individuals with a follow-up of less than 10 years were not included in the lag 10 analysis, and
so on. Cox models with time-dependent covariates were used to estimate hazard ratios (HR)
for incident dementia. The corresponding HRs with longer lags reflect incrementally longer-
term associations. Inverse-probability weights were employed in all the primary analyses to
reduce potential selection bias, with additional information provided (S3 Text) [15].
For the analysis of each of the lag windows (i.e., for lag 0, lag 5, lag 10, and lag 15), the con-
tinuous measure of SBP variation was divided into five categories by the quintiles of all mea-
surements of SBP variation, with the reference group defined as the lowest quintile for
absolute variation and the middle quintile for directional variation. Testing for linear trends
across quintiles of variation in SBP was performed by entering a single ordinal term. We addi-
tionally examined the associations with SBP variation using restricted cubic-spline term to
assess the deviation from linearity [16]. The change in the association over lag periods was fur-
ther examined with 1-year increments in lag from 0 to 15 years.
To control for possible confounding that may affect both SBP variation and dementia risk,
Cox models were built for each of the four time windows described above in the following
three ways: (1) adjustment for age and sex; (2) additional adjustment for mean SBP; (3) adjust-
ment for age, sex, education level, and APOE genotype, as well as time-dependent covariates,
which were updated simultaneously with variation in SBP, including smoking habits, alcohol
consumption, body mass index, lipid levels, history of diabetes and cardiovascular disease, and
antihypertensive medication use at each of the two visits when SBP variation was assessed. All
covariates, except SBP level and age, were categorical, and missing data were handled by add-
ing an additional category indicating missing values (<10%). We also used a multiple-imputa-
tion approach with five imputations in our sensitivity analysis, which showed consistent
results. Findings from the three models were similar, and therefore, results from the final
model are presented.
To identify potential effect modification, we stratified the analyses by antihypertensive
treatment during the study, SBP level at baseline, age, and sex. Interaction was formally tested
on a multiplicative scale by adding a product term to the model. To explore potential mecha-
nisms, we further stratified the association by pulse wave velocity index, the most common
indicator of arterial stiffness [17].
Secondary analyses. We repeated the above analyses for the most common subtypes of
dementia—i.e., Alzheimer’s disease and vascular dementia—for the variation in DBP and
pulse pressure, and for SBP variation using absolute difference in SBP (mmHg per year),
respectively. To account for the competing risk of death, we estimated cause-specific HRs for
dementia and death, respectively [18]. To allow for the comparison with previous studies on
this topic [9,19], we further examined (time-independent) SBP variation over the first three
visits, spanning 6 years, assessed by coefficient of variation and standard deviation. The pro-
portional hazard assumptions were tested by including an interaction term with time in the
model, and the assumptions were also verified. The correlation between these measures was
also assessed.
Sensitivity analyses. To test the robustness of the main findings, we performed the fol-
lowing analyses: (1, 2) excluding participants with a history of cardiovascular disease and dia-
betes mellitus, respectively; (3) censoring SBP measurements after the onset of cardiovascular
disease; (4) restricting analyses to those with SBP measurements at consecutive visits before
censoring; (5) reporting associations without using inverse-probability weighting; (6) imput-
ing missing data using a multiple-imputation approach; (7) censoring participants at the diag-
nosis of stroke to assess the relationship that is not mediated by nonfatal stroke; and (8)
Blood pressure variation and dementia
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estimating how strong residual confounding would need to be to explain away the observed
associations [20].
This study is reported according to the Strengthening the Reporting of Observational Stud-
ies in Epidemiology (STROBE) guidelines (S1 STROBE Checklist). All effect estimates are
given with corresponding 95% confidence intervals (CIs). All P values presented are two sided,
with a P value of 0.05 or less considered statistically significant. Statistical analyses were per-
formed using SAS version 9.4 (SAS Institute) and R version 3.4.2 (R Foundation).
Results
Study population
Of 5,273 participants, 3,063 (58.1%) were women, and the mean (SD) age was 67.6 (8.0) years.
During a median follow-up of 14.6 years (from 1989 to 2016, interquartile range 7.9–20.5),
1,059 participants developed dementia (overall incidence rate: 14.7 cases per 1,000 person-
years), including 802 (75.7%) with Alzheimer’s disease and 80 (7.6%) with vascular dementia.
Table 1 describes the participant characteristics.
Variation in SBP and the risk of dementia
A large SBP variation was associated with a higher risk of dementia. Table 2 and Fig 2 show
the HRs of dementia by quintiles of SBP variation after adjusting for age, sex, education, APOE
genotype, vascular risk factors, and history of cardiovascular disease. In the short-term (lag0),
the risk of dementia was not statistically significantly associated with SBP variation. The mag-
nitude of the association increased with longer intervals between the measurement of SBP vari-
ation and dementia diagnosis, and the HR for a large variation was 3.13 (comparing highest
versus lowest quintile; 95% CI 2.05–4.77, P< 0.001) when measured�15 years ago. The asso-
ciations estimated for every 1-year increase in the lag period from 0 to 15 years demonstrate
an upward trend, which reached statistical significance from a lag period of 1 year onwards
(Fig B in S2 Text).
A stronger association between SBP variation and dementia was noted especially over lon-
ger intervals in those not on antihypertensive treatment during the study (Fig 3). There is no
clear difference in the association estimates according to baseline SBP level (Table B in S2
Text). The association appeared stronger in younger participants aged <70 years and in men
(Table C in S2 Text). It also appeared stronger with the presence of arterial stiffness (Table D
in S2 Text).
Rise or fall in SBP and the risk of dementia
Long-term associations of a large SBP variation with an increased dementia risk were
observed for both large rises and large falls in SBP after adjusting for age, sex, education,
APOE genotype, vascular risk factors, and history of cardiovascular disease (Fig 4, Table 3).
This U-shaped association was enhanced with longer intervals. The HR was 3.31 (comparing
highest versus middle quintile of variation in SBP; 95% CI 2.11–5.18, P< 0.001) with large
rises in SBP and 2.20 (comparing lowest versus middle quintile; 95% CI 1.33–3.63, P = 0.002)
with large falls in SBP occurring �15 years before diagnosis. Short-term associations differed
from the long-term associations, showing modest increased risk of dementia only with large
falls in SBP �5 years before diagnosis (lag0; HR, 1.21; 95% CI 1.00–1.48; P = 0.017. Fig 4,
Table 3).
Blood pressure variation and dementia
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Secondary analyses
The magnitudes of association with large SBP variation were somewhat larger for vascular
dementia than for Alzheimer’s disease (Table E in S2 Text). Similar association was observed
for variation in both DBP (Table F in S2 Text) and pulse pressure (Table G in S2 Text), though
the association estimates for pulse pressure variation appeared smaller with less consistent pat-
terns. The association with SBP variation measured by absolute difference—i.e. in mmHg per
Table 1. Participant characteristics.
Characteristics a Overall (n = 5,273)
Age, years 67.6 ± 8.0
Women, n (%) 3,063 (58.1)
Education, n (%)
Primary education only 1,037 (19.9)
Intermediate education 3,698 (70.8)
Higher vocation/university education 486 (9.3)
APOE genotype, n (%)
ε3/ε3 2,957 (58.4)
ε2/ε2 or ε2/ε3 696 (13.8)
ε2/ε4 or ε3/ε4 1,294 (25.6)
ε4/ε4 113 (2.2)
Systolic blood pressure, mmHg 138 ± 22
Diastolic blood pressure, mmHg 74 ± 11
Pulse pressure, mmHg 64 ± 17
Hypertension, n (%) 3,100 (58.8)
Antihypertensive treatment at baseline, n (%) 1,544 (29.3)
Antihypertensive treatment during follow-up, n (%)
Intermittent treatment 2,010 (38.1)
Continuous treatment 1,107 (21.0)
Weight statusb, n (%)
Overweight 2,465 (47.2)
Obese 762 (14.6)
Smoking status, n (%)
Past 2,184 (42.9)
Current 1,057 (20.8)
Current alcohol drinking, n (%) 3,621 (80.8)
Body mass index, kg/m2 26.3 ± 3.6
Total cholesterol, mmol/L 6.7 ± 1.2
HDL cholesterol, mmol/L 1.4 ± 0.4
History of diabetes, n (%) 336 (6.7)
History of cardiovascular disease, n (%) 669 (12.7)
Stroke, n (%) 101 (1.9)
Coronary heart disease, n (%) 373 (7.1)
Atrial fibrillation, n (%) 203 (3.8)
Heart failure, n (%) 121 (2.3)
Data are shown in the format of mean ± SD and n (%).
aCharacteristics at the first visit after cohort entry unless otherwise specified.
bWeight status was assessed by BMI, with overweight defined as 25� BMI < 30 kg/m2 and obesity defined as
BMI� 30 kg/m2.
Abbreviations: APOE, apolipoprotein E; BMI, body mass index; HDL, high-density lipoprotein
https://doi.org/10.1371/journal.pmed.1002933.t001
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year—remained essentially unchanged (Table H in S2 Text). Cause-specific HRs estimated for
dementia were consistent with primary findings, with similar association patterns observed for
all-cause mortality (Table I in S2 Text). The association of the magnitude of variation in SBP
from the first three visits over 6 years, measured by coefficient of variation and standard devia-
tion, were essentially consistent with the primary findings (Table J in S2 Text). The correlation
between these measures on SBP variation is also provided (Table K in S2 Text).
Sensitivity analyses
Findings were consistent in all the sensitivity analyses (Table L in S2 Text). Specifically, associ-
ation estimates appeared stronger after excluding individuals with cardiovascular disease and
Table 2. Variation in systolic blood pressure and risk of dementia.
Lag periods (years) Events/participants at risk Hazard ratios (95% CI)a
Quintile 1b
(<1.0%/year)
Quintile 2
(1.0~2.1%/year)
Quintile 3
(2.1~3.6%/year)
Quintile 4
(3.6~5.9%/year)
Quintile 5
(�5.9%/year)
P for linear trend
0 1,059/5,273 1 1.09 (0.90–1.31) 1.10 (0.91–1.33) 1.13 (0.93–1.37) 1.08 (0.88–1.34) 0.337
5 878/4,532 1 1.12 (0.91–1.38) 1.15 (0.93–1.42) 1.34 (1.08–1.65) 2.01 (1.60–2.54) <0.001
10 586/3,472 1 1.05 (0.79–1.40) 1.10 (0.82–1.47) 1.15 (0.87–1.51) 1.67 (1.21–2.30) 0.006
15 360/2,565 1 1.05 (0.65–1.70) 1.28 (0.79–2.07) 1.70 (1.08–2.69) 3.13 (2.05–4.77) <0.001
aWith adjustment for age, sex, education level, APOE genotype, and time-dependent covariates on smoking habit, alcohol consumption, the use of antihypertensive
medication, body mass index, lipid level, and history of diabetes and cardiovascular disease.
bReference category.
Abbreviations: APOE, apolipoprotein E; CI, confidence interval
https://doi.org/10.1371/journal.pmed.1002933.t002
Fig 2. Variation in SBP and the risk of dementia. aRef. defined as the lowest quintile, representing the smallest variation in SBP. bAdjusting for age, sex, education
level, APOE genotype, and time-dependent covariates on smoking habits, alcohol consumption, use of antihypertensive medication, body mass index, lipid level, and
history of diabetes and cardiovascular disease. APOE, apolipoprotein E; SBP, systolic blood pressure; CI, confidence interval; Q, quintile; Ref., reference level.
https://doi.org/10.1371/journal.pmed.1002933.g002
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diabetes mellitus at baseline. A final sensitivity analysis showed that, to explain away dementia
risk�5 years after the measurement of SBP variation (HR with a large variation in SBP, 2.01;
95% CI 1.60–2.54), the unmeasured confounding would need to be associated with both a
large SBP variation and dementia by an HR of 3.43 each, above and beyond the measured con-
founders [20].
Discussion
We found that a large blood pressure variation was associated with an increased risk of demen-
tia in a 26-year prospective cohort study. The association appeared stronger as the years
between the measurement of blood pressure variation and the diagnosis of dementia increased.
A higher risk of dementia was observed with both large rises and falls in blood pressure, sug-
gesting that a large variation in blood pressure, rather than the direction of the variation,
increases the risk of dementia.
We observed an increased long-term risk of dementia associated with a large blood pres-
sure variation over a period of years, independent of concurrent blood pressure level. This
observation was in line with a previous study with a shorter follow-up [9]. Another study
observed a significant association of large blood pressure variability with cognitive decline but
not with incident dementia [19]. Together with the body of evidence linking blood pressure
variation to cardiovascular disease and cognitive decline [8,21,22], our finding suggests that a
large blood pressure variation over a period of years may be an important marker of impaired
blood pressure regulation, especially in the aging population. Blood pressure rises throughout
most of life, but in late life, blood pressure varies substantially, and a decline in both SBP and
Fig 3. SBP variation and the risk of dementia by antihypertensive medication. aAdjusting for age, sex, education
level, APOE genotype, and time-dependent covariates on smoking habits, alcohol consumption, body mass index, lipid
level, and history of diabetes and cardiovascular disease. bP values for interaction term (between SBP variation and
antihypertensive medication) were 0.68, 0.74, 0.13, and 0.02, with a lag period of 0, 5, 10, and 15 years, respectively.
APOE, apolipoprotein E; SBP, systolic blood pressure; CI, confidence interval; Q, quintile.
https://doi.org/10.1371/journal.pmed.1002933.g003
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DBP has been observed [23,24]. The timing and determinants for the downward trend in
blood pressure are also unclear [25]. By focusing on variation in blood pressure, this finding
reconciles previous data linking not only large rises but also large falls in blood pressure to
dementia [26–28].
The stronger association of blood pressure variation with dementia over longer intervals is
consistent with the evidence showing that midlife hypertension is especially strongly associated
Table 3. Rise or fall in systolic blood pressure and risk of dementia.
Lag periods (years) Events/participants
at risk
Hazard ratios (95% CI)a
Quintile 1
(<−2.4%/year)
Quintile 2
(−2.4~0.1%/year)
Quintile 3b
(0.1~2.0%/year)
Quintile 4
(2.0~4.3%/year)
Quintile 5
(�4.3%/year)
P for nonlinear trendc
0 1,059/5273 1.21 (1.00–1.48) 0.97 (0.80–1.18) 1 1.11 (0.92–1.34) 1.00 (0.81–1.22) 0.017
5 878/4,532 1.62 (1.30–2.01) 0.99 (0.80–1.22) 1 1.11 (0.91–1.37) 1.49 (1.20–1.84) <0.001
10 586/3,472 1.63 (1.22–2.17) 1.08 (0.80–1.44) 1 0.91 (0.68–1.22) 1.36 (1.03–1.81) <0.001
15 360/2,565 2.20 (1.33–3.63) 1.54 (0.94–2.50) 1 1.55 (0.94–2.53) 3.31 (2.11–5.18) <0.001
aWith adjustment for age, sex, education level, APOE genotype, and time-dependent covariates on smoking habit, alcohol consumption, the use of antihypertensive
medication, body mass index, lipid level, and history of diabetes and cardiovascular disease.
bReference category.
cTest for nonlinearity for the spline term of the rise or fall in systolic blood pressure.
Abbreviations: APOE, apolipoprotein E; CI, confidence interval
https://doi.org/10.1371/journal.pmed.1002933.t003
Fig 4. Rise or fall in SBP and the risk of dementia. aRef. defined as the third quintile, representing the smallest variation in SBP. bAdjusting for age, sex, education
level, APOE genotype, and time-dependent covariates on smoking habits, alcohol consumption, use of antihypertensive medication, body mass index, lipid level, and
history of diabetes and cardiovascular disease. APOE, apolipoprotein E; SBP, systolic blood pressure; CI, confidence interval; Q, quintile; Ref., reference level.
https://doi.org/10.1371/journal.pmed.1002933.g004
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with dementia [29]. This trend suggests a robust relationship that suffers less from reverse cau-
sation. It may also reflect a cumulative effect of chronic augmented fluctuation in cerebral
blood flow. The magnitude of the association tended to be greater for vascular dementia than
for Alzheimer’s disease, consistent with existing evidence [9,30]. The consistent and more pro-
found associations, observed in the absence of antihypertensive treatment and among those of
lower blood pressure, concur with previous reports [9,21,31]. This observation suggests that
the observed association was not explained by the initiation of or the change in antihyperten-
sive medication during the study.
The biological mechanisms underlying the association are largely unknown. A large blood
pressure variation over a period of years, including both large rises and falls, could reflect the
progression of vascular pathology or a progressive impairment of blood pressure regulation
through multiple pathways. The results suggest a possibly more detrimental role of large blood
pressure variation in the presence of elevated pulse wave velocity. One explanation could be
that stiffness of large vessels may increase pulsation of flow and dampen the smoothing of
blood flow as it progresses to small arteries, particularly in high-flow organs such as the brain
[32,33]. Therefore, in the presence of arterial stiffness with advancing age, the exposure to
wider pressure fluctuations, including large rises and falls in blood pressure, may damage the
microvasculature of the brain and cause brain atrophy and cerebral small-vessel disease,
thereby leading to dementia [34]. Age-related endothelial dysfunction could be another expla-
nation. Animal studies suggest that large blood pressure variability could impair endothelial
function by inhibiting nitric oxide production, contributing to “neurovascular unit” injuries
and cerebral small-vessel disease [35,36].
The association of blood pressure variation with the short-term risk of dementia was mod-
erate, as a higher risk was observed only with substantial falls in blood pressure. This observa-
tion was consistent with evidence linking late-life declines in blood pressure to dementia [26].
One explanation is that the lower cerebral autoregulation threshold is more likely to be
impaired and shifts upwards during aging and with hypertension [37], thereby subjecting indi-
viduals with steep declines in blood pressure more vulnerable to cerebral hypoperfusion, a
putative risk factor for dementia [38]. Alternatively, reverse causation is possible. Pathological
changes of prodromal dementia may affect central autonomic regulation to stabilize blood
pressure, resulting in a large variation, especially large falls due to the impairment of sympa-
thetically mediated vasoconstriction [39].
Several limitations need to be acknowledged. First, we measured blood pressure variation
over a period of 2–4 years, which is clearly different from short-term blood pressure variability
over hours, days, and weeks. Assessing blood pressure variation using data from no more than
two visits could attenuate risk estimates because of random measurement error. The consistent
findings from different time windows and the strong dose-response associations indicate that
the pathological changes underlying the variation spanning years were strong enough to mani-
fest themselves even in the presence of random noise. Second, the physiological mechanisms
underlying blood pressure variation over different time intervals are largely unknown, and our
findings may therefore not be generalizable to diurnal, beat-to-beat, and day-to-day variation.
Third, despite the use of inverse-probability weights, including only the surviving individuals in
the analyses with longer lag periods may have introduced selection bias. Fourth, residual con-
founding is possible, although this is unlikely to change our conclusions, given the strength this
unmeasured confounding would need to have to explain away the observed effect estimates.
Finally, reverse causation, a much less likely issue for the long-term associations, is still possible
if prodromal dementia starts 20 years before the diagnosis. This study has several strengths,
including a continuous monitoring and standardized diagnosis of dementia and an investiga-
tion of the association across intervals ranging from 5 years to more than 15 years apart.
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Conclusions
In this study, we observed that a large variation in blood pressure was associated with an
increased risk of dementia. The strength of the association between blood pressure variation
and dementia appeared stronger with longer intervals. Given the paucity of epidemiological
evidence on dementia from long-term prospective studies, this study may offer important
insights into the etiology of dementia. If the observed association is causal, our study suggests
a large potential to prevent dementia through targeting blood pressure variability above and
beyond the mere control of conventional blood pressure limits—for instance, by the preferred
use of calcium channel blockers and non-loop diuretics [40]. Future clinical trials for blood
pressure control to prevent cognitive decline could therefore benefit from incorporating tar-
gets to maintain stable blood pressure over time. The stronger association over longer intervals
thereby suggests greater benefits from interventions implemented earlier in life.
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